10-15 Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $12.8M | Sell |
271,410
-6,058
| -2% | -$285K | 2.48% | 17 |
|
|
2020
Q2 | $14.1M | Buy |
277,468
+2,630
| +1% | +$134K | 2.85% | 8 |
|
|
2020
Q1 | $13M | Buy |
274,838
+17,876
| +7% | +$847K | 3.03% | 6 |
|
|
2019
Q4 | $15.1M | Buy |
256,962
+2,894
| +1% | +$170K | 2.85% | 7 |
|
|
2019
Q3 | $13.6M | Buy |
254,068
+2,866
| +1% | +$153K | 2.79% | 8 |
|
|
2019
Q2 | $12.6M | Buy |
251,202
+5,813
| +2% | +$291K | 2.73% | 11 |
|
|
2019
Q1 | $12.8M | Buy |
245,389
+6,923
| +3% | +$362K | 2.75% | 12 |
|
|
2018
Q4 | $11.4M | Sell |
238,466
-431
| -0.2% | -$20.6K | 2.79% | 12 |
|
|
2018
Q3 | $12M | Buy |
238,897
+5,366
| +2% | +$269K | 2.69% | 11 |
|
|
2018
Q2 | $11.8M | Buy |
233,531
+8,822
| +4% | +$445K | 2.64% | 15 |
|
|
2018
Q1 | $11M | Buy |
224,709
+7,303
| +3% | +$357K | 2.61% | 16 |
|
|
2017
Q4 | $9.64M | Buy |
217,406
+6,730
| +3% | +$298K | 2.31% | 19 |
|
|
2017
Q3 | $10.7M | Buy |
210,676
+18,442
| +10% | +$936K | 2.7% | 13 |
|
|
2017
Q2 | $10.4M | Buy |
192,234
+2,061
| +1% | +$111K | 2.91% | 11 |
|
|
2017
Q1 | $10M | Buy |
190,173
+11,398
| +6% | +$601K | 2.74% | 12 |
|
|
2016
Q4 | $8.61M | Buy |
178,775
+9,909
| +6% | +$477K | 2.41% | 15 |
|
|
2016
Q3 | $9.1M | Buy |
168,866
+1,756
| +1% | +$94.7K | 2.53% | 13 |
|
|
2016
Q2 | $9.05M | Buy |
167,110
+12,712
| +8% | +$689K | 2.6% | 10 |
|
|
2016
Q1 | $7.83M | Sell |
154,398
-460
| -0.3% | -$23.3K | 2.43% | 10 |
|
|
2015
Q4 | $7.81M | Buy |
154,858
+26,257
| +20% | +$1.32M | 2.27% | 12 |
|
|
2015
Q3 | $6.18M | Buy |
128,601
+1,074
| +0.8% | +$51.6K | 2.12% | 18 |
|
|
2015
Q2 | $6.64M | Buy |
127,527
+1,927
| +2% | +$100K | 2.06% | 17 |
|
|
2015
Q1 | $7.25M | Buy |
125,600
+5,220
| +4% | +$301K | 2.42% | 16 |
|
|
2014
Q4 | $6.43M | Buy |
+120,380
| New | +$6.43M | 2.06% | 19 |
|